Impact of Preemptive Therapy for Cytomegalovirus on Toxicities after Allogeneic Hematopoietic Cell Transplantation in Clinical Practice: A Retrospective Single-Center Cohort Study.

Adult Antiviral Agents / adverse effects Cohort Studies Cytomegalovirus Cytomegalovirus Infections / drug therapy Ganciclovir / therapeutic use Hematopoietic Stem Cell Transplantation / adverse effects Humans Retrospective Studies
Acute kidney injury (AKI) Cytomegalovirus (CMV) Foscarnet Ganciclovir Hematopoietic cell transplantation (HCT) Neutropenia Preemptive therapy (PET) Treatment-related toxicity Valganciclovir

Journal

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
ISSN: 1523-6536
Titre abrégé: Biol Blood Marrow Transplant
Pays: United States
ID NLM: 9600628

Informations de publication

Date de publication:
08 2020
Historique:
received: 11 11 2019
revised: 11 03 2020
accepted: 13 03 2020
pubmed: 22 4 2020
medline: 24 6 2021
entrez: 22 4 2020
Statut: ppublish

Résumé

(Val)ganciclovir (vGCV) or foscarnet (FCN) as preemptive therapy (PET) for cytomegalovirus (CMV) after allogeneic hematopoietic cell transplantation (HCT) is associated with myelosuppression and nephrotoxicity, respectively. We analyzed a cohort of CMV-seropositive (R

Identifiants

DOI: 10.1016/j.bbmt.2020.03.019 PMID: 32315708 PMC: PMC8220837
pubmed: 32315708
pii: S1083-8791(20)30177-4
doi: 10.1016/j.bbmt.2020.03.019
pmc: PMC8220837
mid: NIHMS1656295
pii:
doi:

Substances chimiques

Antiviral Agents 0
Ganciclovir P9G3CKZ4P5

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1482-1491

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

Copyright © 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Références

Ann Intern Med. 2015 Jan 6;162(1):1-10
pubmed: 25560711
Blood. 1997 Sep 15;90(6):2502-8
pubmed: 9310503
Clin Infect Dis. 2017 Jan 1;64(1):87-91
pubmed: 27682069
Ann Intern Med. 1993 Feb 1;118(3):173-8
pubmed: 8380242
Ann Intern Med. 1993 Feb 1;118(3):179-84
pubmed: 8380243
Bone Marrow Transplant. 2017 May;52(5):733-738
pubmed: 28092350
Bone Marrow Res. 2012;2012:874601
pubmed: 23243512
Antimicrob Agents Chemother. 1987 Mar;31(3):452-4
pubmed: 3495235
Biol Blood Marrow Transplant. 2016 Aug;22(8):1480-1486
pubmed: 27178374
Int J Hematol. 2009 Mar;89(2):231-237
pubmed: 19148587
Clin Microbiol Infect. 2014 Feb;20(2):160-6
pubmed: 23607363
Blood. 2011 Nov 17;118(20):5689-96
pubmed: 21937692
N Engl J Med. 2017 Dec 21;377(25):2433-2444
pubmed: 29211658
Biol Blood Marrow Transplant. 2019 Sep;25(9):1859-1868
pubmed: 31132455
Mediterr J Hematol Infect Dis. 2016 Jun 20;8(1):e2016031
pubmed: 27413524
Biol Blood Marrow Transplant. 2017 Oct;23(10):1759-1766
pubmed: 28668490
Biol Blood Marrow Transplant. 2020 Feb;26(2):323-332
pubmed: 31618690
Blood. 2002 Feb 15;99(4):1159-64
pubmed: 11830461
Bone Marrow Transplant. 2008 Aug;42(4):227-40
pubmed: 18587440
Blood. 2016 May 19;127(20):2427-38
pubmed: 26884374
Am J Health Syst Pharm. 2010 Sep 1;67(17):1417-25
pubmed: 20720240
Bone Marrow Transplant. 2015 Jun;50(6):834-9
pubmed: 25798671
Transpl Infect Dis. 2018 Aug;20(4):e12897
pubmed: 29668073
Transpl Infect Dis. 2015 Aug;17(4):510-7
pubmed: 25940504
Biol Blood Marrow Transplant. 2016 Feb;22(2):258-267
pubmed: 26325439
Blood. 2009 Jun 4;113(23):5711-9
pubmed: 19299333
Rev Infect Dis. 1988 Jul-Aug;10 Suppl 3:S507-14
pubmed: 2847287
Blood. 1995 Oct 1;86(7):2815-20
pubmed: 7670117
Hematology Am Soc Hematol Educ Program. 2011;2011:305-9
pubmed: 22160050
Bone Marrow Transplant. 1995 Jun;15(6):825-8
pubmed: 7581076
Transpl Infect Dis. 2015 Dec;17(6):810-5
pubmed: 26354293
Bone Marrow Transplant. 2016 Jul;51(7):1010-2
pubmed: 26974271
Biol Blood Marrow Transplant. 2009 Oct;15(10):1143-238
pubmed: 19747629
Expert Rev Anti Infect Ther. 2012 Nov;10(11):1249-64
pubmed: 23167560
Blood. 2000 Apr 1;95(7):2240-5
pubmed: 10733491
Transplantation. 2016 Oct;100(10):e74-80
pubmed: 27495775
Antivir Ther. 2011;16(7):951-7
pubmed: 22024510
Expert Opin Biol Ther. 2012 Sep;12(9):1161-72
pubmed: 22650422
Leuk Lymphoma. 2015 Mar;56(3):663-70
pubmed: 24913499
J Clin Virol. 2002 Aug;25 Suppl 2:S51-6
pubmed: 12361756
N Engl J Med. 2019 Sep 19;381(12):1136-1147
pubmed: 31532960
Clin Infect Dis. 2019 Apr 8;68(8):1255-1264
pubmed: 30329038
J Clin Microbiol. 2015 Apr;53(4):1252-7
pubmed: 25653404
Clin Infect Dis. 2003 Mar 15;36(6):749-58
pubmed: 12627359
J Infect. 2014 Oct;69(4):341-351
pubmed: 24931578
Bone Marrow Transplant. 2010 Mar;45(3):534-42
pubmed: 19668235
Lancet Haematol. 2016 Mar;3(3):e119-27
pubmed: 26947200
Clin Pharmacol Ther. 1986 Sep;40(3):281-6
pubmed: 3017630

Auteurs

Phaedon Zavras (P)

Infectious Disease Service, Memorial Sloan Kettering Cancer Center, New York, New York.

Yiqi Su (Y)

Infectious Disease Service, Memorial Sloan Kettering Cancer Center, New York, New York.

Jiaqi Fang (J)

Infectious Disease Service, Memorial Sloan Kettering Cancer Center, New York, New York.

Anat Stern (A)

Infectious Disease Service, Memorial Sloan Kettering Cancer Center, New York, New York.

Nitasha Gupta (N)

Infectious Disease Service, Memorial Sloan Kettering Cancer Center, New York, New York.

Yuexin Tang (Y)

Center for Observational and Real-World Evidence, Merck & Co., Inc., Kenilworth, New Jersey.

Amit Raval (A)

Center for Observational and Real-World Evidence, Merck & Co., Inc., Kenilworth, New Jersey.

Sergio Giralt (S)

Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.

Miguel Angel Perales (MA)

Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.

Ann A Jakubowski (AA)

Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, New York.

Genovefa A Papanicolaou (GA)

Infectious Disease Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York. Electronic address: papanicg@mskcc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Impact of Preemptive Therapy for...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antiviraux › Impact of Preemptive Therapy for...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Impact of Preemptive Therapy for...
questionsmedicales.fr › Virus › Virus à ADN › Herpesviridae › Betaherpesvirinae › Cytomegalovirus › Impact of Preemptive Therapy for...
questionsmedicales.fr › Infection › Maladies virales › Infections à virus à ADN › Infections à Herpesviridae › Infections à cytomégalovirus › Impact of Preemptive Therapy for...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › Purines › Purinones › Hypoxanthines › Guanine › Aciclovir › Ganciclovir › Impact of Preemptive Therapy for...
questionsmedicales.fr › Procédures de chirurgie opératoire › Transplantation › Transplantation cellulaire › Transplantation de cellules souches › Transplantation de cellules souches hématopoïétiques › Impact of Preemptive Therapy for...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Impact of Preemptive Therapy for...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Impact of Preemptive Therapy for...